As NGAL-R co-exists with CD38 on CLL cells (possibly in lipid rafts), the involvement of NGAL-R in CD38 signaling (and vice versa) might be hypothesized. Here, SLC22A17 is linked to B-cell chronic lymphocytic leukemia.